Common Shares Outstanding: The number of class A shares currently held by investors.
Ampio Pharmaceuticals, Inc. (AMPE) had Common Shares Outstanding of 0.83M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-2.05M |
|
-- |
|
-- |
|
$2.21M |
|
$-2.21M |
|
$0.16M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.21M |
|
$-2.21M |
|
0.81M |
|
0.81M |
|
$-2.13 |
|
$-2.13 |
|
| Balance Sheet Financials | |
$5.74M |
|
-- |
|
-- |
|
$5.74M |
|
$2.38M |
|
-- |
|
-- |
|
$2.38M |
|
$3.36M |
|
$3.36M |
|
$3.36M |
|
|
Common Shares Outstanding |
0.83M |
| Cash Flow Statement Financials | |
$-8.56M |
|
-- |
|
-- |
|
$12.65M |
|
$4.09M |
|
$-8.56M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-61.13% |
|
-61.13% |
|
-35.81% |
|
-61.13% |
|
$4.03 |
|
$-10.57 |
|
$-10.57 |
|